Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Valcavi

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
The Journal of Clinical Endocrinology and Metabolism|February 1, 1993
Pyridostigmine potentiates growth hormone (GH)-releasing hormone-induced GH release in both men and womenE Arvat, M Cappa, F F Casanueva, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1997
In obesity, glucose load loses its early inhibitory, but maintains its late stimulatory, effect on somatotrope secretionS Grottoli, M Procopio, M Maccario, et al.
Clinical Endocrinology|April 1, 1987
Effect of oral administration of melatonin on GH responses to GRF 1-44 in normal subjectsR Valcavi, C Dieguez, C Azzarito, et al.
European Journal of Endocrinology|January 1, 1995
Effect of 15-day treatment with growth-hormone-releasing hormone alone or combined with different doses of arginine on the reduced somatotrope responsiveness to the neurohormone in normal agingE Ghigo, G P Ceda, R Valcavi, et al.
Clinical Endocrinology|August 1, 1985
The influence of oestrogens on the sensitivity of PRL, TSH and LH to the inhibitory actions of dopamine in hyperprolactinaemic patientsR Valcavi, P E Harris, S M Foord, et al.
Clinical Endocrinology|April 1, 1986
Lack of effect of muscarinic cholinergic blockade on the GH responses to GRF 1-29 and TRH in acromegalic subjectsV Jordan, C Dieguez, R Valcavi, et al.
Journal of Endocrinological Investigation|February 1, 1994
Low doses of either intravenously or orally administered arginine are able to enhance growth hormone response to growth hormone releasing hormone in elderly subjectsE Ghigo, G P Ceda, R Valcavi, et al.
Clinical Endocrinology|February 15, 2000
Association of elevated insulin-like growth factor binding protein-1 with insulin resistance in hyperthyroidismR C Jenkins, R Valcavi, M Zini, et al.
Clinical Endocrinology|June 1, 1986
Growth hormone responses to GRF 1-29 in patients with primary hypothyroidism before and during replacement therapy with thyroxineR Valcavi, V Jordan, C Dieguez, et al.
The Journal of Clinical Endocrinology and Metabolism|July 23, 2014
Long-term efficacy of ultrasound-guided laser ablation for benign solid thyroid nodules. Results of a three-year multicenter prospective randomized trialE Papini, T Rago, G Gambelunghe, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
The Journal of Clinical Endocrinology and Metabolism|February 1, 1993
Pyridostigmine potentiates growth hormone (GH)-releasing hormone-induced GH release in both men and womenE Arvat, M Cappa, F F Casanueva, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1997
In obesity, glucose load loses its early inhibitory, but maintains its late stimulatory, effect on somatotrope secretionS Grottoli, M Procopio, M Maccario, et al.
Clinical Endocrinology|April 1, 1987
Effect of oral administration of melatonin on GH responses to GRF 1-44 in normal subjectsR Valcavi, C Dieguez, C Azzarito, et al.
European Journal of Endocrinology|January 1, 1995
Effect of 15-day treatment with growth-hormone-releasing hormone alone or combined with different doses of arginine on the reduced somatotrope responsiveness to the neurohormone in normal agingE Ghigo, G P Ceda, R Valcavi, et al.
Clinical Endocrinology|August 1, 1985
The influence of oestrogens on the sensitivity of PRL, TSH and LH to the inhibitory actions of dopamine in hyperprolactinaemic patientsR Valcavi, P E Harris, S M Foord, et al.
Clinical Endocrinology|April 1, 1986
Lack of effect of muscarinic cholinergic blockade on the GH responses to GRF 1-29 and TRH in acromegalic subjectsV Jordan, C Dieguez, R Valcavi, et al.
Journal of Endocrinological Investigation|February 1, 1994
Low doses of either intravenously or orally administered arginine are able to enhance growth hormone response to growth hormone releasing hormone in elderly subjectsE Ghigo, G P Ceda, R Valcavi, et al.
Clinical Endocrinology|February 15, 2000
Association of elevated insulin-like growth factor binding protein-1 with insulin resistance in hyperthyroidismR C Jenkins, R Valcavi, M Zini, et al.
Clinical Endocrinology|June 1, 1986
Growth hormone responses to GRF 1-29 in patients with primary hypothyroidism before and during replacement therapy with thyroxineR Valcavi, V Jordan, C Dieguez, et al.
The Journal of Clinical Endocrinology and Metabolism|July 23, 2014
Long-term efficacy of ultrasound-guided laser ablation for benign solid thyroid nodules. Results of a three-year multicenter prospective randomized trialE Papini, T Rago, G Gambelunghe, et al.
Pageof 6